This document summarizes research from the Thorax Institute on using induced pluripotent stem cells (iPSCs) to model metabolic diseases like familial hypercholesterolemia (FH). Researchers generated iPSCs from a FH patient and differentiated them into hepatocyte-like cells. These cells reproduced the patient's phenotype of impaired LDL cholesterol uptake and responded to pharmacological treatment. The researchers propose that 3D culture systems could further mature the cells to enable phenotypic screening of diseases like non-alcoholic steatohepatitis and fibrosis.